← Alle mensen

PA

Peter A Kaufman

8 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Abemaciclib Plus Fulvestrant in Gevorderd Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Fase...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 maart 2025

Imlunestrant als preoperatieve orale SERD bij ER-positief mammacarcinoom: window-studie

Clinical cancer research : an official journal of the American Association for Cancer Research · 2 december 2024

Genomische alteraties in ctDNA bij abemaciclib bij mammacarcinoom

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 mei 2024

Amcenestrant versus standaard bij HR-positief mammacarcinoom: AMEERA-3 fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2023

Margetuximab versus trastuzumab bij HER2-positief mammacarcinoom: SOPHIA OS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 januari 2023

Endocriene therapie plus entinostat of placebo bij HR-positief mammacarcinoom: E2112 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 oktober 2021

Abemaciclib plus fulvestrant en totale overleving bij HR-positief mammacarcinoom: MONARCH 2 OS

JAMA oncology · 1 januari 2020

Abemaciclib plus fulvestrant bij HR+/HER2- gevorderd mammacarcinoom na endocriene therapie: MONARCH 2

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2017